CRC Pharma is managed by the following team which has more than forty total years of direct pharma development experience in the planning, execution, and management of statistically related deliverables for clinical trials. A partial listing of companies previously served by the CRC Pharma principals is: Novartis, Johnson and Johnson, Eli Lilly, Schering Plough, Merck, Aventis, Organon and Xoma.
Ramesh Makkena M.S - President
Ramesh Makkena has over 14 years of clinical reporting experience at small and large Pharma and Biotech companies. Mr. Makkena has a high technical knowledge of the SAS language, HL7, ICH CDISC and ADaM standards and principles. He has provided programming expertise to six NME's, including reporting of Phase I-IV individual trials, pooled analysis (e.g. Summary of Clinical Safety, Summary of Clinical Efficacy), exploratory analyses, and responses to Regulatory Authority queries, Mr. Makkena received his Bachelor's and Master's in Computer Applications from Nagarjuna University, India.
William Stewart, Ph.D. - Vice President/Director
Dr. Stewart has over 30 years of clinical trials experience in Phases I-IV as a Biostatistician, Biostatistical Group Head, Biostatistical Quality Group Head, and Statistical Programming Group Head, Dr. Stewart received his Ph.D. in Research Design and Statistics from City University of New York, and also holds a MS in Statistics from Florida State University and a MS in Genetics.